AR109846A1 - Validación de aclaramiento viral continuo - Google Patents
Validación de aclaramiento viral continuoInfo
- Publication number
- AR109846A1 AR109846A1 ARP170102921A ARP170102921A AR109846A1 AR 109846 A1 AR109846 A1 AR 109846A1 AR P170102921 A ARP170102921 A AR P170102921A AR P170102921 A ARP170102921 A AR P170102921A AR 109846 A1 AR109846 A1 AR 109846A1
- Authority
- AR
- Argentina
- Prior art keywords
- validation
- viral clearance
- probe
- continuous viral
- continuous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/22—Testing for sterility conditions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2103/00—Materials or objects being the target of disinfection or sterilisation
- A61L2103/05—Living organisms or biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16194959.9A EP3141611A3 (en) | 2016-10-21 | 2016-10-21 | Validation of continuous viral clearance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109846A1 true AR109846A1 (es) | 2019-01-30 |
Family
ID=57209212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102921A AR109846A1 (es) | 2016-10-21 | 2017-10-20 | Validación de aclaramiento viral continuo |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10894991B2 (https=) |
| EP (2) | EP3141611A3 (https=) |
| JP (1) | JP2019537435A (https=) |
| KR (1) | KR20190066017A (https=) |
| CN (1) | CN110100008A (https=) |
| AR (1) | AR109846A1 (https=) |
| AU (1) | AU2017345412A1 (https=) |
| BR (1) | BR112019007835A2 (https=) |
| CA (1) | CA3041253A1 (https=) |
| IL (1) | IL266095A (https=) |
| MX (1) | MX385466B (https=) |
| RU (1) | RU2755634C2 (https=) |
| SG (1) | SG10202104023QA (https=) |
| TW (1) | TW201827830A (https=) |
| UY (1) | UY37447A (https=) |
| WO (1) | WO2018075716A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3651811A1 (en) * | 2017-07-10 | 2020-05-20 | Baxalta Incorporated | Method for incubating liquids and inactivating viruses |
| US20230103302A1 (en) * | 2020-02-28 | 2023-04-06 | Asahi Kasei Medical Co., Ltd. | Method for evaluating viral clearance capability |
| CA3195893A1 (en) * | 2020-09-21 | 2022-03-24 | Bayer Healthcare Llc | Pathogen clearance system and method |
| US12203914B2 (en) * | 2020-11-12 | 2025-01-21 | Sartorius Bioanalytical Instruments, Inc. | Viral clearance evaluation for biological medical product preparation processes |
| JP7612001B2 (ja) * | 2021-03-26 | 2025-01-10 | 旭化成メディカル株式会社 | ウイルスクリアランス試験の方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012026095A2 (pt) * | 2010-04-14 | 2015-09-15 | Emd Millipore Corp | métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos. |
| AU2014100888A4 (en) * | 2014-08-07 | 2014-09-11 | Novartis Ag | Virus clearance and protein purification methods |
-
2016
- 2016-10-21 EP EP16194959.9A patent/EP3141611A3/en not_active Withdrawn
-
2017
- 2017-10-19 EP EP17791896.8A patent/EP3529367A1/en not_active Withdrawn
- 2017-10-19 AU AU2017345412A patent/AU2017345412A1/en not_active Abandoned
- 2017-10-19 CN CN201780064932.4A patent/CN110100008A/zh active Pending
- 2017-10-19 KR KR1020197010823A patent/KR20190066017A/ko not_active Ceased
- 2017-10-19 TW TW106135849A patent/TW201827830A/zh unknown
- 2017-10-19 MX MX2019004540A patent/MX385466B/es unknown
- 2017-10-19 WO PCT/US2017/057298 patent/WO2018075716A1/en not_active Ceased
- 2017-10-19 JP JP2019520956A patent/JP2019537435A/ja not_active Ceased
- 2017-10-19 RU RU2019115375A patent/RU2755634C2/ru active
- 2017-10-19 CA CA3041253A patent/CA3041253A1/en not_active Abandoned
- 2017-10-19 BR BR112019007835-5A patent/BR112019007835A2/pt not_active IP Right Cessation
- 2017-10-19 SG SG10202104023QA patent/SG10202104023QA/en unknown
- 2017-10-20 UY UY0001037447A patent/UY37447A/es not_active Application Discontinuation
- 2017-10-20 AR ARP170102921A patent/AR109846A1/es not_active Application Discontinuation
- 2017-10-20 US US16/343,125 patent/US10894991B2/en not_active Expired - Fee Related
-
2019
- 2019-04-17 IL IL266095A patent/IL266095A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019115375A (ru) | 2020-11-23 |
| EP3141611A2 (en) | 2017-03-15 |
| SG10202104023QA (en) | 2021-06-29 |
| EP3141611A3 (en) | 2017-05-10 |
| MX2019004540A (es) | 2019-06-12 |
| RU2019115375A3 (https=) | 2021-03-19 |
| WO2018075716A1 (en) | 2018-04-26 |
| AU2017345412A1 (en) | 2019-04-18 |
| IL266095A (en) | 2019-06-30 |
| CN110100008A (zh) | 2019-08-06 |
| JP2019537435A (ja) | 2019-12-26 |
| EP3529367A1 (en) | 2019-08-28 |
| TW201827830A (zh) | 2018-08-01 |
| BR112019007835A2 (pt) | 2019-10-01 |
| US10894991B2 (en) | 2021-01-19 |
| US20190316213A1 (en) | 2019-10-17 |
| MX385466B (es) | 2025-03-18 |
| CA3041253A1 (en) | 2018-04-26 |
| UY37447A (es) | 2018-05-31 |
| KR20190066017A (ko) | 2019-06-12 |
| RU2755634C2 (ru) | 2021-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR109846A1 (es) | Validación de aclaramiento viral continuo | |
| CL2019000278A1 (es) | Agentes rnai para infección con virus de hepatitis b. | |
| IL280559A (en) | Hepatitis b virus (hbv) dsrna agent compositions and methods of use thereof | |
| CL2014002551A1 (es) | Metodo para identificar segmento de audio, que comprende las etapas de crear un espectrograma del segmento candidato de audio, crear un mapa candidato de bits huella digital y acustica del espectrograma, comparar el mapa candidato con al menos un mapa conocido de un mensaje de red conocido, si el mapa candidato coincide con un mapa conocido, declarar el calce, y si el candidato no coincide, utilizar un algoritmo de deteccion para analizar el segmento de audio candidato; metodos asociados. | |
| IL256644B (en) | System and method for management, execution, and analysis of laboratory experiments | |
| CO2017003490A2 (es) | Moléculas de anticuerpos a pd-l1 | |
| CL2018001156A1 (es) | Preparación de muestras para muestras difíciles. | |
| DK3643795T3 (da) | Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering | |
| BR112015015975A2 (pt) | moléculas de dsrna isoladas e métodos de uso das mesmas para silenciamento das moléculas alvo de interesse. | |
| DK3224755T3 (da) | Statistisk analysefremgangsmåde til bestemmelse af risiko ved filbaseret indhold | |
| IL249503A0 (en) | Scanning electron microscope and methods of inspecting and reviewing samples | |
| MA52506A (fr) | Procédés de traitement d'infections par des virus nipah | |
| MX2015012437A (es) | Esteroides neuroactivos, composiciones, y usos de los mismos. | |
| DK3325664T3 (da) | Analyse af fragmenteringsmønstre for cellefrit DNA | |
| IL271147A (en) | Methods for accurate computational decomposition of dna mixtures from contributors of unknown genotypes | |
| IL253710B (en) | Biomarkers for pancreatic cancer and kits and methods for detecting same | |
| DK3389679T3 (da) | Fremgangsmåde til lyofilisering af en prøve af fækal mikrobiota | |
| EP3414650A4 (en) | SOCIAL KEYBOARD | |
| PE20180171A1 (es) | Neutralizacion del virus chikungunya mediada por anticuerpos | |
| EP3630732A4 (en) | Method and molecules | |
| MX2016013877A (es) | Composiciones y metodos para mejorar y/o predecir la amplificacion de adn. | |
| MX2017003635A (es) | Metodo para medir la reactividad del factor de coagulacion viii (fviii). | |
| NI201600147A (es) | Métodos y aparato para la coordinación de la selección del sistema entre un conjunto de nodos | |
| BR112018008757A2 (pt) | suspensor de liner | |
| EP3625349A4 (en) | MODIFIED VIRUSES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |